ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Via Transportation, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VIA

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Via Transportation, Inc. (NYSE: VIA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Via’s initial public offering (the “IPO” or “Offering”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026.

SO WHAT: If you purchased Via common stock pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, the Offering Documents used to effectuate Via’s IPO were false and misleading and omitted to state that, at the time of the IPO, Via’s growth had already begun to encounter obstacles because of Via’s declining Platform Annual Run-Rate Revenue and inability to grow in Germany. As these facts emerged after the IPO, Via shares fell sharply. By the commencement of this action, Via’s shares traded as low as $14.52, a decline of nearly 70% from the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Via class action, go to https://rosenlegal.com/cases/via-transportation-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————-

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

GlobeNewswire Distribution ID 9748877

Publication relating to transparency notifications

        REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), June 17, 2026, 10:30 pm CET / 4:30 pm ET In accordance with article 14 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received transparency notifications as detailed below.

Robert Taub

On June 16, 2026, Nyxoah received a transparency notification from Robert Taub following an acquisition of voting securities by Robert Taub and Robelga SRL (an entity controlled by Robert Taub). Based on the notification, on June 10, 2026, Robert Taub (together with Robelga SRL) held 14,440,277 voting rights, representing 14.45% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 50,000 equivalent financial instruments, representing 0.05% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 16, 2026 contains the following information:

  • Reason for the notification: acquisition or disposal of voting securities or voting rights
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Robert Taub
    • Robelga SRL (with address at Avenue des Croix de Guerre 149 / 13, 1120 Brussels)
  • Date on which the threshold was crossed: June 10, 2026
  • Threshold that is crossed: 10%
  • Denominator: 99,926,284
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Robert Taub 2,712,510 6,766,564 6.77%
Robelga SRL 1,598,290 7,673,713 7.68%
Subtotal 4,310,800 14,440,277 14.45%
TOTAL 14,440,277 0 14.45% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights that may be acquired if the instrument is exercised % of voting rights Settlement
Robert Taub Warrants 08/06/2027 25,000 0.03% cash
Robert Taub Warrants 14/06/2028 25,000 0.03% cash
TOTAL 50,000 0.05%
TOTAL (A & B) # of voting rights % of voting rights
14,490,277 14.50%
  • Full chain of controlled undertakings through which the holding is effectively held: Robelga SRL is 100% owned by BMI Estate (a partnership (société simple) without legal personality). Robert Taub has 100% usufruct and Robert Taub’s children have 100% bare ownership of BMI Estate.

Pierre-Edouard Stérin

On June 17, 2026, Nyxoah received a transparency notification from Pierre-Edouard Stérin following an acquisition of voting securities by B.A.D. 21 SRL (an entity controlled by Pierre-Edouard Stérin). Based on the notification, on June 10, 2026, Pierre-Edouard Stérin (taking into account the holdings of his affiliates) held 7,221,666 voting rights, representing 7.23% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 17, 2026 contains the following information:

  • Reason for the notification: acquisition or disposal of voting securities or voting rights
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Pierre-Edouard Stérin
    • Lemahieu Holding SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
    • Graal Holding SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
    • B.A.D. 21 SRL (with address at Rue Haute 21, 1380 Lasne, Belgium)
  • Date on which the threshold was crossed: June 10, 2026
  • Threshold that is crossed: 5%
  • Denominator: 99,926,284
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Pierre-Edouard Stérin 0 0 0.00% 0.00%
Lemahieu Holding SRL 0 0 0.00% 0.00%
Graal Holding SRL 0 0 0.00% 0.00%
B.A.D. 21 SRL 7,221,666 0 7.23% 0.00%
Subtotal 7,221,666 7.23%
TOTAL 7,221,666 0 7.23% 0.00%
  • Full chain of controlled undertakings through which the holding is effectively held: B.A.D. 21 SRL is controlled by Graal Holding SRL, which itself is controlled by Lemahieu Holding SRL, which is controlled by Mr. Pierre-Edouard Stérin.

Cochlear Limited

On June 16, 2026, Nyxoah received a transparency notification from Cochlear Limited following the passive crossing of a threshold by Cochlear Investments Pty Ltd (an entity controlled by Cochlear Limited). Based on the notification, on June 10, 2026, Cochlear Limited (taking into account the holding of its affiliate) held 5,847,283 voting rights, representing 5.85% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 15, 2026 contains the following information:

  • Reason for the notification: passive crossing of a threshold
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Cochlear Limited (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
    • Cochlear Investments Pty Ltd (with address at 1 University Avenue, Macquarie University, NSW 2109, Australia)
  • Date on which the threshold was crossed: June 10, 2026
  • Threshold that is crossed: 10%
  • Denominator: 99,926,284
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Cochlear Limited 0 0 0 0.00% 0.00%
Cochlear Investments Pty Ltd 5,631,319 5,847,283 0 5.85% 0.00%
Subtotal 5,631,319 5,847,283 5.85%
TOTAL 5,847,283 0 5.85% 0.00%
  • Full chain of controlled undertakings through which the holding is effectively held: Cochlear Investments Pty Ltd is a wholly owned subsidiary of Cochlear Limited, which is listed on the Australian Securities Exchange and has no controlling shareholder.
  • Additional information: Cochlear Investments Pty Ltd acquired 215,964 ordinary shares in Nyxoah pursuant to a private placement completed on November 18, 2025, resulting in an increase of its shareholding to 5,847,283 ordinary shares which did not trigger any crossing of a threshold.

This notification concerns a downwards crossing of the 10% threshold following a passive decrease, whereby Cochlear Investments Pty Ltd’s holding in Nyxoah fell from 14.999% (as previously notified in September 2025) and 13.08% immediately prior to the capital increase, to 5.85% of the voting rights.
We understand the underwriters have been granted a 30-day option to subscribe for up to an additional 8,284,883 ordinary shares, which could further reduce Cochlear’s holding to 5.40% without crossing any additional disclosure threshold.

Gilde Healthcare Holding B.V.

On June 16, 2026, Nyxoah received a transparency notification from Gilde Healthcare Holding B.V. following the passive downward crossing of the lowest threshold.

The notification dated June 15, 2026 contains the following information:

  • Reasons for the notification:
    • Passive crossing of a threshold
    • Downward crossing of the lowest threshold
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Gilde Healthcare Holding B.V. (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
    • Gilde Healthcare III Management B.V. (with address at Stadsplateau 36, 3521 AZ Utrecht, the Netherlands)
  • Date on which the threshold was crossed: June 10, 2026
  • Threshold that is crossed: 3%
  • Denominator: 99,926,284
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Gilde Healthcare Holding B.V.
Gilde Healthcare III Management B.V.
TOTAL
  • Full chain of controlled undertakings through which the holding is effectively held: Gilde Healthcare III Management B.V. is controlled by Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is not a controlled entity.
  • Additional information: Cooperatieve Gilde Healthcare III Sub-Holding UA and Cooperatieve Gilde Healthcare III Sub-Holding 2 UA hold the shares in Nyxoah. Gilde Healthcare III Management B.V. is the management company of these two entities, that in the absence of specific instructions can exercise the voting rights at its discretion.

Bank of America Corporation

On June 15, 2026, Nyxoah received a transparency notification from Bank of America Corporation following an acquisition of voting securities and of financial instruments that are treated as voting securities by entities that are controlled by Bank of America Corporation. Based on the notification, on June 10, 2026, Bank of America Corporation (taking into account the holdings of its affiliates) held 449,288 voting rights, representing 0.45% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 2,971,370 equivalent financial instruments, representing 2.97% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 12, 2026 contains the following information:

  • Reason for the notification:
    • Acquisition or disposal of voting securities or voting rights
    • Acquisition or disposal of financial instruments that are treated as voting securities
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Bank of America Corporation (with address at 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, United States of America)
  • Date on which the threshold was crossed: June 10, 2026
  • Threshold that is crossed: 3%
  • Denominator: 99,926,284
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Bank of America Corporation 0 0.00%
Bank of America, National Association 7,319 0.01%
BofA Securities, Inc. 393,157 0.39%
Merrill Lynch International 48,812 0.05%
Subtotal 449,288 0.45%
TOTAL 449,288 0 0.45% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights that may be acquired if the instrument is exercised % of voting rights Settlement
Merrill Lynch International Right to recall 15,001 0.02% physical
Merrill Lynch International Rights of use 1 0.00% physical
BofA Securities, Inc. Rights of use 1,873,387 1.87% physical
BofA Securities, Inc. Right to recall 1,080,480 1.08% physical
Bank of America, NA Swap 15/10/2027 991 0.00% cash
Merrill Lynch International Swap 15/02/2028 519 0.00% cash
Merrill Lynch International Swap 15/10/2027 991 0.00% cash
TOTAL 2,971,370 2.97%
TOTAL (A & B) # of voting rights % of voting rights
3,420,658 3.42%
  • Full chain of controlled undertakings through which the holding is effectively held: Bank of America, National Association, BofA Securities, Inc. and Merrill Lynch International are controlled by Bank of America Corporation. Bank of America Corporation is not a controlled entity.

Bank of America Corporation

On June 15, 2026, Nyxoah received a transparency notification from Bank of America Corporation following the disposal of voting securities and of financial instruments that are treated as voting securities by entities that are controlled by Bank of America Corporation resulting in the downward crossing of the lowest threshold. Based on the notification, on June 10, 2026, Bank of America Corporation (taking into account the holdings of its affiliates) held 269,166 voting rights, representing 0.27% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284), and 2,551,461 equivalent financial instruments, representing 2.55% of the total number of shares issued by Nyxoah on June 10, 2026 (99,926,284).

The notification dated June 15, 2026 contains the following information:

  • Reason for the notification:
    • Downward crossing of the lowest threshold
    • Acquisition or disposal of voting securities or voting rights
    • Acquisition or disposal of financial instruments that are treated as voting securities
  • Notification by: a parent undertaking or a controlling person
  • Persons subject to the notification requirement:
    • Bank of America Corporation (with address at 1209 Orange Street – Corporation Trust Center, Wilmington DE 19801, United States of America)
  • Date on which the threshold was crossed: June 11, 2026
  • Threshold that is crossed: 3%
  • Denominator: 99,926,284
  • Notified details:
A) Voting rights Previous notification After the transaction
# of voting rights # of voting rights % of voting rights
Holders of voting rights Linked to securities Not linked to the securities Linked to securities Not linked to the securities
Bank of America Corporation 0 0 0.00%
Bank of America, National Association 7,319 7,319 0.01%
BofA Securities, Inc. 393,157 216,277 0.22%
Merrill Lynch International 48,812 45,570 0.05%
Subtotal 449,288 269,166 0.27%
TOTAL 269,166 0 0.27% 0.00%
B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights that may be acquired if the instrument is exercised % of voting rights Settlement
Merrill Lynch International Right to recall 15,000 0.02% physical
BofA Securities, Inc. Rights of use 1,445,424 1.45% physical
BofA Securities, Inc. Right to recall 1,088,536 1.09% physical
Bank of America, NA Swap 15/10/2027 991 0.00% cash
Merrill Lynch International Swap 15/02/2028 519 0.00% cash
Merrill Lynch International Swap 15/10/2027 991 0.00% cash
TOTAL 2,551,461 2.55%
TOTAL (A & B) # of voting rights % of voting rights
2,820,627 2.82%
  • Full chain of controlled undertakings through which the holding is effectively held: Bank of America, National Association, BofA Securities, Inc. and Merrill Lynch International are controlled by Bank of America Corporation. Bank of America Corporation is not a controlled entity.

Contact:
Nyxoah
John Landry, CFO
[email protected]

Attachment

GlobeNewswire Distribution ID 1001188347

Nyxoah Receives $15 Million from the European Investment Bank

Non-dilutive debt funding complements the Company’s June equity raise, bringing total capital raised to $110 million

Mont-Saint-Guibert, Belgium – June 17, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced that it has received $15 million (€13.8 million) in proceeds from the second tranche of its loan facility with the European Investment Bank (EIB). The drawdown follows the recent confirmation that the Company had satisfied the predefined criteria required to access this tranche.

With this drawdown, Nyxoah has raised approximately $110 million in total new capital in June 2026, combining the proceeds of its underwritten public offering with this non-dilutive EIB financing.

The EIB proceeds are intended first and foremost to accelerate the commercial launch of Genio in the United States, while also supporting continued investment in research and development and the scale-up of manufacturing. As non-dilutive capital, the EIB financing reinforces the Company’s balance sheet without diluting existing shareholders.

“Receiving these funds from the European Investment Bank completes a transformative financing for Nyxoah,” said Olivier Taelman, Chief Executive Officer. “The EIB’s continued support is a strong endorsement of our technology and of the long-term potential of our mission to make sleep simple for OSA patients. This non-dilutive capital, alongside the equity proceeds raised this month, allows us to accelerate the commercial launch of Genio in the United States while continuing to invest in innovation. We are entering the next phase of our growth from a position of strength.”

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study and receipt of approval from the FDA for a subset of adult patients with moderate to severe OSA with an AHI of greater than or equal to 15 and less than or equal to 65.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. FDA approved in August 2025 as prescription-only device.

Forward-looking statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or management’s current expectations regarding the intended use of the proceeds under the second tranche of the European Investment Bank loan; the Company’s capital position; the Genio system; the potential advantages of the Genio system; and the Company’s commercialization strategy and growth in the U.S. market. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. These risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 26, 2026 and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah

John Landry, CFO

[email protected]

Rémi Renard, Head of Investor Relations & Corporate Communication

[email protected]

Attachment

GlobeNewswire Distribution ID 1001188313

Smartbird Appoints New CEO to Advance AI Infrastructure Strategy

Nadia Carlsten, AI and advanced computing industry leader, appointed president,
CEO and board member

Independent Director Lily Yan Hughes appointed as board chair

Allbirds, Inc. name changed to Smartbird, Inc.

SAN FRANCISCO, June 17, 2026 (GLOBE NEWSWIRE) — Smartbird, Inc. (NASDAQ: BIRD), an AI infrastructure provider, today announced the appointment of Nadia Carlsten as president and chief executive officer. Carlsten has also joined Smartbird’s board of directors.

The company has completed its previously announced definitive agreement to sell the Allbirds brand and footwear assets. With the transition to Smartbird now completed, the company also strengthened its balance sheet by increasing the size of its convertible financing facility from $50 million to $100 million. The expanded capital base provides Smartbird with additional resources to execute its AI infrastructure strategy.

A visionary and builder, Carlsten brings decades of deep technical expertise in AI compute infrastructure combined with commercial execution across platform scaling, go-to-market, partnerships and capital strategy. She has served as a trusted partner to boards and investors, with a strong track record of building high-performing teams, stewarding capital and generating strong returns on investment.

While serving as CEO of DCAI, an AI company delivering large-scale GPU compute infrastructure and enterprise AI, Carlsten launched a sovereign AI supercomputer in partnership with NVIDIA. As vice president of product at Google spin-off SandboxAQ, Carlsten led the product portfolio across AI, security and hardware platforms. She has also done extensive work on advanced computing platforms, including launching Amazon’s quantum computing service during her tenure at Amazon Web Services.

Carlsten actively contributes to global technology discourse, advising on strategy, investment decisions and scaling of AI and digital platforms. As a member of the World Economic Forum’s Global Future Council on Next Generation Computing, Carlsten advises on the strategic implications of advanced computing and AI infrastructure.

Carlsten holds bachelor degrees in chemistry and physics from the University of Virginia, and a doctorate in engineering from the University of California, Berkeley.

Carlsten replaces Joe Vernachio, who is resigning from the company and the board of directors. Annie Mitchell will continue to serve as chief financial officer, a position she has held for the past three years. Lily Yan Hughes, who has served as an independent director of the company since October 2025, has been appointed board chair. Hughes has extensive technology experience and a 30-year track record of operational excellence across corporate governance, capital markets and corporate finance.

“We are thrilled to usher in this new era of the company with Nadia at the helm. Her groundbreaking work and visionary mindset will be instrumental in establishing a foothold in the market and building a scalable long-term solution for enterprise customers,” said Hughes. “The board selected Nadia because of the breadth of her experience and demonstrated success delivering breakthrough ideas and initiatives at scale. The pairing of her vision and expertise with Annie’s continued financial leadership make us confident in the trajectory of the business and our ability to build long-term shareholder value.”

The rise of AI development and adoption has created unprecedented structural demand for specialized, high-performance compute. The AI infrastructure market is entering a new phase as enterprises move from experimentation to production-scale deployment, creating demand for dedicated infrastructure that is more flexible and cost-efficient than traditional hyperscale cloud offerings. Smartbird delivers dedicated AI infrastructure as a managed service, providing the performance, control, and scalability of ownership without the capital investment and operational complexity. The company is in active discussions with prospective customers across its target verticals and is currently designing its first cluster deployments.

“Smartbird is entering the market at a pivotal moment in the evolution of AI infrastructure,” said Dr. Carlsten, CEO of Smartbird. “AI is rapidly becoming mission-critical for organizations across every industry, yet many organizations lack a practical path to deploy and operate the dedicated infrastructure these workloads require.

There is a clear opportunity to meet the growing need for enterprise-grade AI infrastructure that delivers control and performance without the capital and operational burden of hardware ownership. With a differentiated strategy, significant capital, and the opportunity to build an exceptional team, we are uniquely positioned to capitalize on one of the most significant infrastructure opportunities of the next decade.”

About Smartbird, Inc.
Smartbird delivers dedicated AI infrastructure as a service, giving organizations the performance, control, and security of a private AI cluster without requiring them to finance, operate, or maintain the underlying infrastructure. Smartbird manages the entire lifecycle, from procurement and deployment to operations and hardware refreshes, so customers can focus on AI workloads, not AI infrastructure.

Stock Information
Effective today, Allbirds, Inc. has changed its name to Smartbird, Inc. The company’s Class A common stock listed on the Nasdaq Global Select Market will continue to trade under the ticker symbol “BIRD” and its CUSIP number remains unchanged.

Inducement Grant
The company has approved, as a material inducement to Dr. Carlsten entering into employment with the company, a restricted stock unit award (“RSU Award”) that is intended to qualify as an “inducement grant” in accordance with Nasdaq Listing Rule 5635(c)(4). The RSU Award is comprised of 1,532,379 RSUs converting into an equal number of shares of the Class A common stock, with 255,397 shares vesting immediately and the remaining shares vesting in 16 equal quarterly installments.

Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on management’s current beliefs, assumptions, and information, and include statements other than historical facts—such as statements regarding future financial performance, profitability, cost savings, business strategy, and objectives of management. Forward-looking statements can often be identified by words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “target,” “will,” or similar expressions. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including: our ability to execute our new business strategy and achieve financial targets; future results of operations, financial condition, business strategy and plans; unfavorable economic conditions; and our ability to obtain additional capital. A further discussion of these and other factors that could cause financial results, performance, and achievements to differ materially from any results, performance, or achievements anticipated, expressed, or implied by these forward-looking statements is included in the filings we make with the SEC, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q and other reports we may file with the SEC from time to time. These forward-looking statements speak only as of the date of this press release, and we undertake no obligation to update them except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in or expressed by, and you should not place undue reliance on our forward-looking statements.

Investor Contact:

[email protected]

Media Contact:

[email protected]

GlobeNewswire Distribution ID 9748379

Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA

Strategic expansion of botanical extracts portfolio strengthens regional support for beauty and personal care and pharmaceutical customers

Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA

Strategic expansion of botanical extracts portfolio strengthens regional support for beauty and personal care and pharmaceutical customers

Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA

“Partnering with American Distilling in EMEA helps position us as a leading and trusted distributor for this product range while strengthening our botanical extract offering,” said Nick Powell, CEO of Ingredients + Specialties from Univar Solutions. “We’ve long supported these specialty ingredients in North America, and with a robust supply chain and experienced technical teams now available regionally, we’re able to offer local stock and faster supply availability to customers.”

ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) — Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions” or “the Company”), a leading global solutions provider to users of specialty ingredients and chemicals, today announced an expanded distribution partnership with American Distilling through its Ingredients + Specialties from Univar Solutions division. Under the new agreement, Univar Solutions will distribute American Distilling’s portfolio of high-quality, natural specialty ingredients. The agreement includes traditional witch hazel (alcohol-free options and customizable grades) for personal care, cosmetic, and pharmaceutical applications across select European, Middle Eastern, and African (EMEA) markets*.

“Partnering with American Distilling in EMEA helps position us as a leading and trusted distributor for this product range while strengthening our botanical extract offering,” said Nick Powell, CEO of Ingredients + Specialties from Univar Solutions. “We’ve long supported these specialty ingredients in North America, and with a robust supply chain and experienced technical teams now available regionally, we’re able to offer local stock and faster supply availability to customers.”

Witch hazel is a multifunctional botanical extract used in facial care, cleansers, body washes, hair care, eye gels, and personal hygiene products. Native to the woodlands of the Northeastern United States, this Hamamelis-derived ingredient offers natural astringent, anti-inflammatory, antioxidant, and antimicrobial benefits. As a gentle, plant-based alternative to synthetic astringents, it supports a broad range of applications, from toners and moisturizers to pads, ointments, creams, sprays, and therapeutic formulations, enhancing both natural content and overall product performance.

“This partnership represents an important step in bringing high-quality United States Pharmacopeia (USP) witch hazel products to customers across the EMEA region,” said Bryan Jackowitz, vice president of American Distilling, Inc. “By collaborating with Univar Solutions, we are now able to market our full portfolio of cosmetic and pharmaceutical witch hazel extracts, giving customers greater flexibility to identify the solution that best fits their specific application needs, with a robust distribution infrastructure to help strengthens their supply chains. We are excited about the long-term potential of this collaboration and look forward to growing together.”

With the addition of this portfolio, Univar Solutions further solidifies its position as a leading distributor of high-performance ingredients for brands shaping the next generation of beauty, personal care, and pharmaceutical products. Customers benefit from the Company’s comprehensive formulation support, advanced laboratory capabilities, deep market insights, and robust distribution network. The Company also offers access to its global Solution Center in Essen, Germany, providing regional support for product development and scale-up.

Learn more about Ingredients + Specialties from Univar Solutions’ portfolio and technical capabilities.

*Markets in agreement include: Albania, Algeria, Austria, Belgium, Bosnia, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Herzegovina, Hungary, Germany, Greece, Ireland,, Italy, Latvia, Lithuania, Luxembourg, Macedonia, Moldovia, Monaco, Morrocco, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, the Netherlands, Tunisia, Turkey, Ukraine, and United Kingdom.

About Univar Solutions
Univar Solutions is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world’s leading producers. With one of the industry’s largest private transportation fleets and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean, and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.

About Ingredients + Specialties from Univar Solutions
Ingredients + Specialties from Univar Solutions brings the best products, people, and results to specialty customers and suppliers seeking to power modern life. By combining science, innovation, and deep expertise with a leading specialty portfolio, we help find the solutions needed to safely improve lives and communities across the globe. Learn more at univarsolutions.com.

About American Distilling
American Distilling is committed to maintaining our position as the industry leader, supplying the health and beauty care and pharmaceutical industries with the highest quality, sustainable distilled Witch Hazel ingredient products. Their talented staff of professionals is dedicated to providing the highest standards of customer service, personal integrity, and consumer value. Each day, they demonstrate their expertise by producing “excellence assured” ingredients for formulations and assisting with new product development to form long-term partnerships with their valued customers. Learn more at americandistilling.com.

Forward-Looking Statements and Information
This communication contains “forward-looking statements” under applicable law regarding financial and operating items relating to the Company’s business. Forward-looking statements generally can be identified by words such as “believes,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “intends,” “plans,” “estimates,” “anticipates” or other comparable terms. All forward-looking statements made in this communication are qualified by this cautionary language.

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company’s control, that could result in expectations not being realized or could otherwise materially and adversely affect the Company’s business, financial condition, results of operations or cash flows. Although the forward-looking statements are based on what management believes to be reasonable assumptions, we caution you that the forward-looking information presented in this communication is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this communication. For additional information regarding factors that could affect the Company, please see the Company’s most recent annual report and other financial reports, including the information set forth under the caption “Risk Factors.” Any forward-looking statements represent the Company’s views only as of the date of this communication and should not be relied upon as representing the Company’s views as of any subsequent date, and the Company undertakes no obligation, other than as may be required by law, to update any forward-looking statement.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/1a0f125e-9860-41fc-bd5d-3e4b878928a1

https://www.globenewswire.com/NewsRoom/AttachmentNg/c253a85c-ac7c-4f0e-9eac-36644f8af1e8

GlobeNewswire Distribution ID 9748380

New KAICIID Policy Paper Challenges Media to Rethink Its Role in Peacebuilding

Should Journalists Have an Active Role in Building Peace?

Lisbon, Portugal, June 17, 2026 (GLOBE NEWSWIRE) — Latest research points ethical journalism when in covering interreligious and intercultural stories/issues can bridge the gap between public awareness and interfaith dialogue achievements says the Dialogue Journalism Fellowship 

Lisbon, June 2026: The King Abdullah bin Abdulaziz International Centre for Interreligious and Intercultural Dialogue (KAICIID)  published today the ‘Media for Peace: Peacebuilding Through Interreligious Dialogue, a comprehensive policy paper produced by its Dialogue Journalism Fellowship in the Arab Region that argues for transforming the relationship between journalism and interreligious dialogue worldwide.

Among the paper’s key findings: media narratives that frame political conflicts in religious terms, or that prioritise sensationalism over stories of dialogue and coexistence, actively undermine the work of religious leaders, institutions and civil society actors who have made significant strides in interreligious understanding over the past three decades. Hate speech practiced by public figures, citizens and journalists alike has found particularly dangerous amplification on social media platforms.

Peacebuilding cannot remain confined to conference rooms, policy papers or formal dialogue spaces. For dialogue to take root, it must reach the public through stories that are accurate, ethical and grounded in lived realities. This policy paper recognises journalists as essential partners in that process, not only as observers of conflict, but as actors who can help communities better understand one another, challenge harmful narratives and create space for coexistence,” said Waseem Haddad, Senior Programme Manager, KAICIID Arab Region.

The paper, grounded in systematic literature review and expert interviews with leading media practitioners, religious leaders and peace experts, identifies three critical roles media can play to advance social cohesion: simplifying and humanising complex theological concepts; bridging divides across religious and ethnic communities; and amplifying the voices and initiatives of grassroots peacebuilders.

Journalists and other media have the power to transform public understanding of religious diversity and coexistence,” said Maya Sukar, Programme Officer – KAICIID Arab Region. “Yet that power remains systematically underutilised. This paper builds on the five years of experience within the programme and is a call to action for journalists, editors, religious institutions and policymakers to build a new kind of partnership, one that puts peace at the centre of the editorial mission of pluralism and peace.”

The paper outlines detailed recommendations for media institutions, religious institutions and policy makers, including calls for journalist training in interreligious and intercultural dialogue, conflict-sensitive and religiously literate reporting, the creation of dedicated media spaces for constructive interfaith dialogue, and the development of media policies and laws that align with the values of peacebuilding and coexistence.

READ THE FULL POLICY PAPER  in English and Arabic

You can download the Policy Paper here.

About KAICIID

The King Abdullah bin Abdulaziz International Centre for Interreligious and Intercultural Dialogue (KAICIID)  is an intergovernmental organisation whose mandate is to promote the use of dialogue to prevent and resolve conflict, and to enhance understanding and cooperation. KAICIID serves as a neutral convener for dialogue between followers of different religions and cultures, in support of sustainable peace.

About the Dialogue Journalism Fellowship

KAICIID’s Dialogue Journalism Fellowship builds the capacity of journalists and media practitioners across the Arab region to cover religion and interreligious dialogue with sensitivity, accuracy and a constructive lens. The Fellowship is part of KAICIID’s Arab Region Programme, which supports ethical media engagement with peacebuilding across the MENA region.

Assets Available

 

  • Full policy paper (PDF)  in English and Arabic
  • KAICIID Secretary General & Arab Region Programme Team available for interviews
  • Dialogue Journalism Fellows available for comment

Attachment

Yvonne Baraza
The King Abdullah bin Abdulaziz International Centre for Interreligious and Intercultural Dialogue (KAICIID) 
+351 960 267 863
[email protected]

GlobeNewswire Distribution ID 9748463